Share Name Share Symbol Market Type Share ISIN Share Description
Venture Life Group Plc LSE:VLG London Ordinary Share GB00BFPM8908 ORD 0.3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 6.15% 34.50 33.00 36.00 34.50 32.30 32.50 1,549,463 13:45:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 18.8 0.7 0.4 82.1 29

Venture Life Group PLC Result of AGM

03/06/2019 11:36am

UK Regulatory (RNS & others)


Venture Life (LSE:VLG)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Venture Life Charts.

TIDMVLG

RNS Number : 9478A

Venture Life Group PLC

03 June 2019

3 June 2019

Venture Life Group plc

("Venture Life" or the "Group")

Result of AGM

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that at its Annual General Meeting held earlier today, all resolutions were duly passed.

For further information, please contact:

 
 Venture Life Group PLC                               +44(0) 1344 578004 
 Jerry Randall, Chief Executive Officer 
 
 Cenkos Securities Ltd (Nomad and Broker)             +44(0)20 7397 8900 
 Mark Connelly / Stephen Keys / Cameron MacRitchie 
  (Corporate Finance) 
 Russell Kerr / Michael Johnson (Sales) 
 
                                                      +44(0)20 3405 
 Alma PR                                               0208 
Hilary Buchanan / Helena Bogle / Jessica Joynson 
 
 

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGUOORRKAANRAR

(END) Dow Jones Newswires

June 03, 2019 06:36 ET (10:36 GMT)

1 Year Venture Life Chart

1 Year Venture Life Chart

1 Month Venture Life Chart

1 Month Venture Life Chart
Your Recent History
LSE
VLG
Venture Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200224 18:23:40